%0 Journal Article %A Miguel A. DurĂ¡n-Olivencia %A Serafim Kalliadasis %T Understanding soaring coronavirus cases and the effect of contagion policies in the UK %D 2021 %R 10.1101/2021.01.30.21250822 %J medRxiv %P 2021.01.30.21250822 %X The number of new daily SARS-CoV-2 infections is frantically rising in almost every country of the EU. The phenomenological explanation offered is a new mutation of the virus, first identified in the UK. We use publicly available data in combination with a controlled SIR model, which captures the effects of preventive measures on the active cases, to show that the current wave of infections is consistent with a single transmission rate. This suggests that the new SARS-CoV-2 variant is as transmissible as previous strains. Our findings indicate that the relaxation of preventive measures is closely related with the ongoing surge in cases. We simulate the effects of new restrictions and vaccination campaigns in 2021, demonstrating that lockdown policies are not fully effective to flatten the curve. For effective mitigation, it is critical that the public keeps on high alert until vaccination reaches a critical threshold.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge financial support from the Engineering and Physical Sciences Research Council of the UK via grant No. EP/L020564/1Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Research only involves theoretical epidemiological data, no IRB oversight is required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data for the analysis was collected from https://www.worldometers.info/coronavirus/country/uk/ https://www.worldometers.info/coronavirus/country/uk/ %U https://www.medrxiv.org/content/medrxiv/early/2021/02/01/2021.01.30.21250822.full.pdf